Clinical Trials in Nottingham, UK

Clinical Trials in Nottingham

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Active, closed

Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

NCT02598661Myelodysplastic Syndromes

Geron Corporation

Phase 2/3

289

Leeds, Nottingham, Southampton, Aberdeen

2016-01-12

Active, closed

Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)

NCT02542293Non Small Cell Lung Carcinoma NSCLC

AstraZeneca

Phase 3

953

Guildford, London, Manchester, Metropolitan Borough of Wirral, Nottingham, Taunton, Wolverhampton

2015-11-03

Active, closed

A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)

NCT02411448Metastatic Non-Small Cell Lung Cancer

Eli Lilly and Company

Phase 3

545

London, Chelsea, Nottingham

2015-05-06

Active, closed

An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma

NCT02213926Mantle Cell Lymphoma (MCL)

Acerta Pharma BV

Phase 2

124

Cardiff, Leeds, Leicester, Nottingham, Oxford, Plymouth, Southampton

2015-03-02

Active, closed

Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

NCT01933932Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV

AstraZeneca

Phase 3

510

Aberdeen, London, Manchester, Nottingham, Sutton, Wolverhampton

2013-09-25

Active, closed

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

NCT01838512Multiple Myeloma

Bristol-Myers Squibb

Observational

2,555

Truro, Leeds, Liverpool, Nottingham, Stafford, Swansea

2012-06-13

Active, closed

A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies

NCT00781612Neoplasm Metastasis

Genentech, Inc.

Phase 2

378

Dundee, Edinburgh, Grimsby, Lancaster, London, Manchester, Middlesex, Nottingham

2008-10-16

Recruiting

Exactech Shoulder Post Market Clinical Follow-up Study

NCT05603728Osteo Arthritis Shoulders, Osteonecrosis, Rotator Cuff Tears, Rotator Cuff Tear Arthropathy

Exactech

Observational

20,000

Reading, Yeovil, Bath, Bedford, Ipswich, Leicester, Manchester, Nottingham

2007-07-19

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 September 2026. https://priyalifescience.com/clinical-trials-uk/city/nottingham

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →